Steven W. Kerrigan

4.0k citations

51 papers · 3.1k indexed · 1 hit paper · h-index 29

Infectious Diseases top 2%
Molecular Biology top 10%
Hematology top 1%
Public Health, Environmental and Occupational Health top 2%
Surgery top 5%

Co-authors: Dermot Cox Steve P. Watson Fergal J. O’Brien Amro Widaa Timothy J. Foster Desmond J. Fitzgerald Tânia Claro Nicola Kavanagh
Topics: Streptococcal Infections and Treatments (23 papers)Platelet Disorders and Treatments (20 papers)Antimicrobial Resistance in Staphylococcus (17 papers)
Cited by: Hematology Infectious Diseases Periodontics
Journals: Blood Gastroenterology PLoS ONE
Partner nations: Ireland United Kingdom United States

In The Last Decade

Steven W. Kerrigan

51 papers receiving 3.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Staphylococcal Osteomyelitis: Disease Progression, Treatment Challenges, and Future Directions

2018 373 citations Nicola Kavanagh, Amro Widaa et al. profile →

Peers

Countries citing papers authored by Steven W. Kerrigan

Since Specialization

Citations

This map shows the geographic impact of Steven W. Kerrigan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Steven W. Kerrigan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Steven W. Kerrigan more than expected).

Fields of papers citing papers by Steven W. Kerrigan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Steven W. Kerrigan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Steven W. Kerrigan. The network helps show where Steven W. Kerrigan may publish in the future.

Co-authorship network of co-authors of Steven W. Kerrigan

This figure shows the co-authorship network connecting the top 25 collaborators of Steven W. Kerrigan. A scholar is included among the top collaborators of Steven W. Kerrigan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Steven W. Kerrigan. Steven W. Kerrigan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Screening medical students for SARS-CoV-2 to facilitate face-to-face clinical teaching and prevent onward spread to patients 2023 ·Journal of Hospital Infection ·Chiara De Santi,Gianpiero L. Cavalleri,Steven W. Kerrigan,Fidelma Fitzpatrick,(unknown),(unknown),Roger Baxter,(unknown),(unknown),H. Humphreys	1
2	Integrins as Therapeutic Targets for SARS-CoV-2 2022 ·Frontiers in Cellular and Infection Microbiology ·(unknown),(unknown),Juan Pablo Robles,Tione Buranda,Steven W. Kerrigan,Gregory Bix	11
3	Human endothelial cell-derived exosomal microRNA-99a/b drives a sustained inflammatory response during sepsis by inhibiting mTOR expression 2022 ·Frontiers in Cellular and Infection Microbiology ·(unknown),(unknown),(unknown),Claire E. McCoy,Gerard F. Curley,Steven W. Kerrigan	11
4	Intra-vital imaging of mesenchymal stromal cell kinetics in the pulmonary vasculature during infection 2021 ·Scientific Reports ·Claire Masterson,Arata Tabuchi,Grace Hogan,(unknown),Steven W. Kerrigan,Mirjana Jerkić,Wolfgang M. Kuebler,John G. Laffey,Gerard F. Curley	32
5	SARS-CoV-2 uses major endothelial integrin αvβ3 to cause vascular dysregulation in-vitro during COVID-19 2021 ·PLoS ONE ·(unknown),Nicola F. Fletcher,Gerard F. Curley,Steven W. Kerrigan	48
6	Educating pharmacy students through a pandemic: Reflecting on our COVID-19 experience 2021 ·Research in Social and Administrative Pharmacy ·Judith Strawbridge,John Hayden,Tracy Robson,Michelle Flood,Shane Cullinan,Matthew Lynch,(unknown),(unknown),(unknown),Steven W. Kerrigan,Gianpiero L. Cavalleri,Brian P. Kirby,Orna Tighe,(unknown),James W. Barlow	6
7	A new perspective in sepsis treatment: could RGD-dependent integrins be novel targets? 2020 ·Drug Discovery Today ·(unknown),Gerard F. Curley,Steven W. Kerrigan	16
8	Inhibition of major integrin αVβ3 reduces Staphylococcus aureus attachment to sheared human endothelial cells 2016 ·Journal of Thrombosis and Haemostasis ·(unknown),Carolina D. Garciarena,(unknown),(unknown),(unknown),Jorien Claes,Peter Verhamme,Philip M. Cummins,Steven W. Kerrigan	33
9	Towards 3D in vitro models for the study of cardiovascular tissues and disease 2016 ·Drug Discovery Today ·Alan J. Ryan,(unknown),Carolina D. Garciarena,Steven W. Kerrigan,Fergal J. O’Brien	26
10	Staphylococcus epidermidis serine–aspartate repeat protein G (SdrG) binds to osteoblast integrin alpha V beta 3 2015 ·Microbes and Infection ·Tânia Claro,Nicola Kavanagh,Timothy J. Foster,Fergal J. O’Brien,Steven W. Kerrigan	12
11	A novel role for the fibrinogen Asn-Gly-Arg (NGR) motif in platelet function 2014 ·Thrombosis and Haemostasis ·(unknown),Ciara A. McManus,Matthew Lambert,Dorothea Ogmore Tilley,Marc Devocelle,Marian Brennan,Steven W. Kerrigan,Dermot Cox	8
12	Obesity Management in the Pharmacy 2011 ·Pharmacy Education ·Steven W. Kerrigan,(unknown),Paul Gallagher	1
13	Staphylococcus aureus Protein A Binds to Osteoblasts and Triggers Signals That Weaken Bone in Osteomyelitis 2011 ·PLoS ONE ·Tânia Claro,Amro Widaa,Maghnus O’Seaghdha,Helen Miajlović,Timothy J. Foster,Fergal J. O’Brien,Steven W. Kerrigan	130
14	Platelets and the innate immune system: mechanisms of bacterial‐induced platelet activation 2011 ·Journal of Thrombosis and Haemostasis ·Dermot Cox,Steven W. Kerrigan,Steve P. Watson	229
15	Invasive Streptococcus pneumoniae trigger platelet activation via Toll‐like receptor 2 2010 ·Journal of Thrombosis and Haemostasis ·C Keane,Dorothea Ogmore Tilley,(unknown),Albert Smolenski,Aras Kadioglu,Dermot Cox,Howard F. Jenkinson,Steven W. Kerrigan	76
16	The thrombotic potential of oral pathogens 2009 ·Journal of Oral Microbiology ·Steven W. Kerrigan,Dermot Cox	9
17	Helicobacter pylori-induced inhibition of vascular endothelial cell functions: a role for VacA-dependent nitric oxide reduction 2008 ·American Journal of Physiology-Heart and Circulatory Physiology ·Nicholas P. Tobin,Gary T. Henehan,Ronan P. Murphy,John C. Atherton,(unknown),Steven W. Kerrigan,Dermot Cox,Paul A. Cahill,Philip M. Cummins	25
18	Molecular Basis for Staphylococcus aureus –Mediated Platelet Aggregate Formation Under Arterial Shear In Vitro 2007 ·Arteriosclerosis Thrombosis and Vascular Biology ·Steven W. Kerrigan,Niamh Clarke,Tony Loughman,Gerardene Meade,Timothy J. Foster,Dermot Cox	77
19	A serine‐rich glycoprotein of Streptococcus sanguis mediates adhesion to platelets via GPIb 2005 ·British Journal of Haematology ·(unknown),Hui Wu,Steven W. Kerrigan,Gerardene Meade,Dermot Cox,C.W.I. Douglas	156
20	Helicobacter pylori binds von Willebrand factor and interacts with GPIb to induce platelet aggregation 2003 ·Gastroenterology ·Michael F. Byrne,Steven W. Kerrigan,Paul A. Corcoran,John C. Atherton,Frank E. Murray,Desmond J. Fitzgerald,Dermot Cox	140

About Steven W. Kerrigan

Steven W. Kerrigan is a scholar working on Hematology, Microbiology and Infectious Diseases, having authored 51 papers that have together received 3.1k indexed citations. Recurring topics across this work include Streptococcal Infections and Treatments (23 papers), Platelet Disorders and Treatments (20 papers) and Antimicrobial Resistance in Staphylococcus (17 papers). The work is most often cited by research in Hematology (810 citations), Infectious Diseases (819 citations) and Periodontics (184 citations). Steven W. Kerrigan has collaborated with scholars based in Ireland, United Kingdom and United States. Frequent co-authors include Dermot Cox, Steve P. Watson, Fergal J. O’Brien, Amro Widaa, Timothy J. Foster, Timothy J. Foster, Desmond J. Fitzgerald, Tânia Claro, Nicola Kavanagh and Howard F. Jenkinson. Their work appears in journals such as Blood, Gastroenterology and PLoS ONE.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact